We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BIS market cap is 3.56M. The company's latest EPS is USD -0.8265 and P/E is -21.95.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 391k | 2k | 3k | 99k | 168k |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -14.02M | -4.48M | 1.85M | -3.51M | -162k |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 31 May 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 22.33M | 15.58M | 8.85M | 6.44M | 3.92M |
| Total Liabilities | 9.78M | 5.91M | 427k | 1.32M | 422k |
| Total Equity | 12.56M | 9.67M | 8.42M | 5.12M | 3.5M |
| Market Cap | 3.56M |
| Price to Earnings Ratio | -21.95 |
| Price to Sales Ratio | 21.16 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 1.02 |
| Dividend Yield | - |
| Shares Outstanding | 196k |
| Average Volume (1 week) | 4.38k |
| Average Volume (1 Month) | 10.57k |
| 52 Week Change | 4.37% |
| 52 Week High | 21.10 |
| 52 Week Low | 14.05 |
| Spread (Intraday) | 9.92 (52.21%) |
| Company Name | ProShares UltraShort NASDAQ Biotechnology |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
